moxifloxacin has been researched along with enbucrilate in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (enbucrilate) | Trials (enbucrilate) | Recent Studies (post-2010) (enbucrilate) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 1,936 | 107 | 812 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gelperina, S; Heifets, L; Higgins, MP; Kisich, KO; Oganesyan, E; Shipulo, E; Wilson, S | 1 |
| Bou-Chacra, N; Clas, SD; Gao, Y; Löbenberg, R; Roa, W; Sarfraz, M; Shi, W | 1 |
2 other study(ies) available for moxifloxacin and enbucrilate
| Article | Year |
|---|---|
Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Aza Compounds; Bacillus subtilis; Biological Assay; Cells, Cultured; Drug Compounding; Enbucrilate; Fluoroquinolones; Humans; Macrophages; Moxifloxacin; Mycobacterium tuberculosis; Nanoparticles; Particle Size; Quinolines; Rhodamines; Suspensions | 2007 |
Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Cyanoacrylates; Cytokines; Drug Carriers; Drug Liberation; Dynamic Light Scattering; Enbucrilate; Enzyme-Linked Immunosorbent Assay; Fluoroquinolones; Gelatin; Macrophages; Mice; Microscopy, Electron, Transmission; Moxifloxacin; Nanoparticles; Rifampin; Spectrophotometry, Ultraviolet; Tuberculosis | 2016 |